NSC |
Compound |
Enrichment |
Correlation |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.00338965595190746 |
0.50435242 |
NSC 762901 |
trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide |
0.00338965595190746 |
0.40170735 |
NSC 728553 |
4-Phenylethynyl-3-(3,4,5-trimethoxy-phenyl)-5H-furan-2-one |
0.00349006332443474 |
0.47027736 |
NSC 749161 |
Null |
0.00349006332443474 |
0.27632039 |
NSC 751956 |
Null |
0.00349006332443474 |
0.40724777 |
NSC 92909 |
ANTINEOPLASTIC-92909 |
0.00349006332443474 |
0.37733674 |
NSC 750493 |
2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one |
0.00361053534040666 |
0.40454399 |
NSC 107043 |
Null |
0.00485717408280859 |
0.27953693 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.00485717408280859 |
0.29277624 |
NSC 176328 |
Ellipticine, 6-(3-aminopropyl)-, dihydrochloride |
0.00485717408280859 |
0.34703158 |